Evotec Share Price
NASDAQ: EVO | OthersEvotec Stock Performance
Evotec Share Price Chart
Evotec Annual Profit & Loss
All figures in USD
Evotec Balance Sheet
All figures in USD Million
Evotec Cash Flow
All figures in USD Million
Corporate Actions
About Evotec
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Evotec Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.53 | $1.45 | -4.61% |
Oct 2026 | $1.65 | $1.52 | -11.11% |
Sep 2026 | $1.81 | $1.71 | -12.31% |
Aug 2026 | $1.96 | $1.95 | +1.04% |
Jul 2026 | $2.89 | $1.93 | -31.07% |
Jun 2026 | $3.07 | $2.80 | -8.79% |
May 2026 | $3.11 | $3.07 | -0.97% |
Apr 2026 | $2.57 | $3.10 | +24.50% |
Mar 2026 | $3.30 | $2.49 | -26.98% |
Feb 2026 | $3.53 | $3.41 | -6.83% |
Jan 2026 | $3.20 | $3.66 | +16.56% |
Dec 2025 | $3.21 | $3.14 | -4.99% |